Our data support a model that the direct entry of BG34-200-AF647 to circulating CD11b+ cells facilitated the plasma clearance of the compound and showed an impact on the cell migration and differentiation in the context of advanced melanoma (Figure 2 and Figure 3). This evidence concerns the gene ITGAM and melanoma.